Anthony Parker
Net worth: 233 541 $ as of 2026-05-30
Net worth: 233 541 $ as of 2026-05-30
Anthony Michael Parker is the founder of Beagle Partners LLP, founded in 2004, where he holds the title of Partner.
He is also the founder of Argonaute RNA Ltd., founded in 2015, where he holds the title of Chairman.
Currently, Mr. Parker is a Non-Executive Director at Allergy Therapeutics Plc.
He is also a Director at Bristol Bluegreen Ltd., Cbderma Technology Ltd., Inverpharma Ltd., Las Lilas Ltd., and Rosemont Wildwall Ltd.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-06-29 | 1,925,000 ( 0.03% ) | 233 541 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ALLERGY THERAPEUTICS PLC | Director/Board Member | 2022-12-05 |
Beagle Partners LLP
Beagle Partners LLP Investment ManagersFinance Beagle Partners specializes in investments with high capital growth potential. They are active in identifying companies with growth businesses both within Emerging Industries and Emerging Markets. The firm is also active providing investment advice in special situations, helping strategic investors with management engagement and executing strategies for active shareholder involvement. | Chief Executive Officer | 2003-12-31 |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Founder | 2014-12-31 |
Bristol Bluegreen Ltd.
Bristol Bluegreen Ltd. Electronic Production EquipmentElectronic Technology Develops voltage management and energy conservation products for domestic & commercial use | Director/Board Member | - |
Cbderma Technology Ltd. | Director/Board Member | - |
Inverpharma Ltd. | Director/Board Member | - |
Las Lilas Ltd. | Director/Board Member | - |
Rosemont Wildwall Ltd. | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Allergy Therapeutics Plc
Allergy Therapeutics Plc Pharmaceuticals: OtherHealth Technology Manufactures subcutaneous and sublingual immunotherapy treatments for a wide range of allergic conditions | Health Technology |
Beagle Partners LLP
Beagle Partners LLP Investment ManagersFinance Beagle Partners specializes in investments with high capital growth potential. They are active in identifying companies with growth businesses both within Emerging Industries and Emerging Markets. The firm is also active providing investment advice in special situations, helping strategic investors with management engagement and executing strategies for active shareholder involvement. | Finance |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Commercial Services |
Bristol Bluegreen Ltd.
Bristol Bluegreen Ltd. Electronic Production EquipmentElectronic Technology Develops voltage management and energy conservation products for domestic & commercial use | Electronic Technology |
Cbderma Technology Ltd. | |
Inverpharma Ltd. | |
Las Lilas Ltd. | |
Rosemont Wildwall Ltd. |
Select your edition
All financial news and data tailored to specific country editions